These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 34097193)

  • 1. Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?
    Castro P; Palomo M; Moreno-Castaño AB; Fernández S; Torramadé-Moix S; Pascual G; Martinez-Sanchez J; Richardson E; Téllez A; Nicolas JM; Carreras E; Richardson PG; Badimon JJ; Escolar G; Diaz-Ricart M
    Cardiovasc Drugs Ther; 2022 Jun; 36(3):547-560. PubMed ID: 34097193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19.
    Six I; Guillaume N; Jacob V; Mentaverri R; Kamel S; Boullier A; Slama M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
    Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
    Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-associated Lung Microvascular Endotheliopathy: A "From the Bench" Perspective.
    Joffre J; Rodriguez L; Matthay ZA; Lloyd E; Fields AT; Bainton RJ; Kurien P; Sil A; Calfee CS; Woodruff PG; Erle DJ; Hendrickson C; Krummel MF; Langelier CR; Matthay MA; Kornblith LZ; Hellman J; ;
    Am J Respir Crit Care Med; 2022 Oct; 206(8):961-972. PubMed ID: 35649173
    [No Abstract]   [Full Text] [Related]  

  • 6. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury.
    Nicosia RF; Ligresti G; Caporarello N; Akilesh S; Ribatti D
    Am J Pathol; 2021 Aug; 191(8):1374-1384. PubMed ID: 34033751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19.
    Rodríguez C; Luque N; Blanco I; Sebastian L; Barberà JA; Peinado VI; Tura-Ceide O
    Am J Respir Cell Mol Biol; 2021 Apr; 64(4):407-415. PubMed ID: 33180562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
    Norooznezhad AH; Mansouri K
    Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
    Rossouw TM; Anderson R; Manga P; Feldman C
    Front Immunol; 2022; 13():776861. PubMed ID: 35185878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling.
    Jadaun PK; Chatterjee S
    Cytokine Growth Factor Rev; 2022 Feb; 63():69-77. PubMed ID: 34728151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19.
    Perico L; Benigni A; Casiraghi F; Ng LFP; Renia L; Remuzzi G
    Nat Rev Nephrol; 2021 Jan; 17(1):46-64. PubMed ID: 33077917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options.
    Pelle MC; Zaffina I; Lucà S; Forte V; Trapanese V; Melina M; Giofrè F; Arturi F
    Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
    Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
    Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial injury exacerbates coronavirus disease 2019: The role of endothelial glycocalyx protection.
    Okada H; Yoshida S; Hara A; Ogura S; Tomita H
    Microcirculation; 2021 Apr; 28(3):e12654. PubMed ID: 32791568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
    Maruhashi T; Higashi Y
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19.
    Wang X; Sahu KK; Cerny J
    J Thromb Thrombolysis; 2021 Apr; 51(3):657-662. PubMed ID: 33063256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses.
    Nascimento Conde J; Schutt WR; Gorbunova EE; Mackow ER
    mBio; 2020 Dec; 11(6):. PubMed ID: 33310781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.